Screener
Nektar Therapeutics NKTR Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|---|---|---|---|
| Other income (expense), net (including income of $2 and $321 for the three months ended March 31, 2026 and 2025, respectively, from a related party) | (336) | 266 | |
| Total non-operating income (expense), net | (4,036) | (1,834) | |
| Loss before provision for income taxes and equity method investment | (43,090) | (46,369) | |
| Provision for income taxes | 64 | 52 | |
| Loss before equity method investment | (43,154) | (46,421) | |
| Loss from equity method investment | (1,750) | (4,461) | |
| Net loss | $ | $$(44,904) | (50,882) |
| Basic and diluted net loss per share | $ | $$(1.82) | (3.62) |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's income tax?
- Nektar Therapeutics (NKTR) reported income tax of $64K in Q1 2026.
- How has Nektar Therapeutics's income tax changed year-over-year?
- Nektar Therapeutics's income tax increased by 23.1% year-over-year, from $52K to $64K.
- What is the long-term trend for Nektar Therapeutics's income tax?
- Over 3 years (2021 to 2024), Nektar Therapeutics's income tax has grown at a -24.8% compound annual growth rate (CAGR), from $561K to -$239K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Nektar Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude